Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05727059 · ClinicalTrials.gov registry record · NA
Magenta Elevate™ EFS in High-Risk PCI Patients
A NA study, sponsored by Magenta Medical.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT05727059 is a NA study that has completed, run by Magenta Medical. The registered enrollment target is 18 participants.
The verdict
NCT05727059, a NA study, has completed, sponsored by Magenta Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The Elevate™ EFS study is designed to evaluate the safety and feasibility of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in patients undergoing non-emergent, high-risk percutaneous coronary interventions.
Interventions
- DEVICE The Elevate™ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-05-08 |
| Est. Completion | 2024-01-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05727059
The ClinicalTrials.gov registry entry for NCT05727059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Magenta Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The Elevate™ System is the first listed.
NCT05727059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05727059 about?
NCT05727059 is a clinical study titled "Magenta Elevate™ EFS in High-Risk PCI Patients". The Elevate™ EFS study is designed to evaluate the safety and feasibility of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in patients undergoing non-emergent, high-risk percutaneous coronary interventions.
What is the current status of trial NCT05727059?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2023-05-08. Estimated completion is 2024-01-02.
What interventions are being tested in trial NCT05727059?
The interventions under investigation include: The Elevate™ System (DEVICE).
Who is sponsoring clinical trial NCT05727059?
This trial is sponsored by Magenta Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.